AMR ACTION FUND
AMR Action Fund renders investment, healthcare, biotech, research and development, pharmaceutical, and antibiotic services. They invest in firms that are developing critical pathogen therapies and lobby for market reforms to transform how society values these lifesaving drugs. They aim to help launch two to four new antimicrobials over the next decade and build a sustainable investment environment.
AMR ACTION FUND
Industry:
Biotechnology Health Care Market Research Pharmaceutical
Founded:
2020-01-01
Status:
Active
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF SSL By Default HSTS Microsoft Exchange Online Cloudflare JS Office 365 Mail CDN JS Microsoft Azure DNS
Similar Organizations
iCeutica
iCeutica offers the healthcare industry with technology solutions that focus on pharmaceutical products development.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Oncoceutics
Oncoceutics, Inc. is a drug discovery and development company targeting the most potent suppressor pathways in human cancer.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Zeno Pharm
Zeno Pharm operates in the healthcare industry focusing on the pharmaceutical business.
Current Advisors List
Board_member
2020-12-01
Board_member
2020-12-01
Board_member
2021-01-01
Current Employees Featured
Henry Skinner Chief Executive Officer @ AMR Action Fund
Chief Executive Officer
2021-03-01
Sergei Petukhov Managing Director @ AMR Action Fund
Managing Director
2021-07-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-06-17 | Elion Therapeutics | AMR Action Fund investment in Series B - Elion Therapeutics | 81 M USD |
| 2024-03-06 | BIOMx | AMR Action Fund investment in Post-IPO Equity - BIOMx | 50 M USD |
| 2023-12-12 | Antabio | AMR Action Fund investment in Series B - Antabio | 25 M EUR |
| 2023-06-13 | Adaptive Phage Therapeutics | AMR Action Fund investment in Series B - Adaptive Phage Therapeutics | 12 M USD |
| 2023-04-25 | Vedanta Biosciences | AMR Action Fund investment in Series E - Vedanta Biosciences | 106.5 M USD |
| 2023-01-05 | BioVersys | AMR Action Fund investment in Series C - BioVersys | 8.4 M CHF |
| 2022-04-04 | Venatorx Pharmaceuticals | AMR Action Fund investment in Series C - Venatorx Pharmaceuticals | 34 M USD |
| 2022-04-04 | Adaptive Phage Therapeutics | AMR Action Fund investment in Series B - Adaptive Phage Therapeutics | 20 M USD |
More informations about "AMR Action Fund"
AMR Action Fund - IFPMA
AMR Action Fund. The industry-led AMR Action Fund organized by IFPMA is a groundbreaking USD 1 billion initiative that aims to bring 2-4 new antibiotics to patients by 2030. ... This was in collaboration with the World Health …See details»
About Us - AMR Action Fund
The AMR Action Fund recognizes the complex nature of expanding access to antibiotics globally, given the challenges of ensuring appropriate use and reducing the development of resistance. Similar to other therapeutic areas, the …See details»
AMR Action Fund - Global Health Progress
Largest pharmaceutical industry-backed collective venture fund …
April 4, 2022, Geneva – The international trade body representing the biopharmaceutical industry (IFPMA) today welcomes the announcement of the AMR Action Fund’s first portfolio …See details»
The AMR Action Fund announces its first non-industry investments ...
Feb 18, 2021 The AMR Action Fund announces its first non-industry investments, raising an additional US$140 million toward addressing antimicrobial resistance (AMR) - AMR Action …See details»
AMR Action Fund - Bayer
The AMR Action Fund is the largest collaborative venture ever created to address antimicrobial resistance (AMR). The concept of the AMR Action Fund was developed by the IFPMA and its member biopharmaceutical companies, in …See details»
AMR Action fund – NIRO
The AMR Action Fund is a public-private partnership investing in the development of new antimicrobial therapeutics. It focuses investments in clinical-stage companies that are …See details»
New AMR Action Fund steps in to save collapsing …
Jul 9, 2020 The AMR Action Fund expects to invest more than US$1 billion with the support of future partners into a portfolio of companies to address the funding gap for the financing of antibiotic development. The Fund is expected to be …See details»
AMR Action Fund - Global Health Progress
The concept of the AMR Action Fund has been developed in collaboration with the World Health Organization, the European Investment Bank, and the Wellcome Trust. It aims to overcome …See details»
AMR Action Fund Opens European Office
Feb 7, 2022 About the AMR Action Fund The AMR Action Fund is the world’s largest public-private partnership supporting the development of antibiotics, antifungals, and other …See details»
Tackling the next health crisis: pharma launches $1bn AMR Action …
Jul 16, 2020 More than 20 major biopharmaceutical companies, the World Health Organization (WHO), the Wellcome Trust and the European Investment Bank (EIB) have launched the …See details»
Fleming Fund projects launched with CARPHA, UKHSA and PAHO …
May 6, 2025 The UK Department of Health and Social Care's Fleming Fund is the world’s single largest Official Development Assistance (ODA) investment in global AMR surveillance. It …See details»
AMR action fund - vmrcindia.com
The concept of the AMR Action Fund was developed by the international body representing the R&D pharmaceutical industry (International Federation of Pharmaceutical Manufacturers & …See details»
Apply to be a member of the WHO civil society task force on ...
May 7, 2025 Applications must be submitted no later than 31 May 2025The World Health Organization (WHO) is pleased to announce a call for expressions of interests from …See details»
The AMR Action Fund announces its first non-industry ... - IFPMA
Feb 18, 2021 The AMR Action Fund, launched in July 2020, aims to bring 2 to 4 new antibiotics to patients by the end of the decade and facilitate needed long-term solutions. ... non-profit …See details»
Action Research
Action research involves a cyclical process of planning, acting, observing, and reflecting, which ensures that interventions are continuously refined based on real-world feedback. ... In …See details»
AMR Action Fund Appoints Scientific Advisory Board
Feb 1, 2022 Members will play a vital role in evaluating potential investments into clinical-stage companies developing urgently needed antibiotics. FEBRUARY 1, 2022, BOSTON, MA - The …See details»
amr Eldessouky - Woodbridge, Virginia, United States - LinkedIn
Amr Eldessouky Student at Northern Virginia Community College Woodbridge, Virginia, United States. See your mutual connectionsSee details»
AMR Action Fund Announces First Investments in Adaptive Phage ...
Apr 4, 2022 The concept of the AMR Action Fund was developed by the International Federation of Pharmaceutical Manufacturers & Associations and its member biopharmaceutical …See details»
Government of Canada supports climate action by Earth Rangers ...
Aug 28, 2020 Climate Action Fund provides up to $3 million annually to support projects delivered by students, youth, Indigenous peoples and organizations, not-for-profit …See details»